(Q40755970)

23 September 2017

A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients (English)

1 reference

23 September 2017

1 reference

Cony-Makhoul P

1

1 reference

23 September 2017

Brossard G

2

1 reference

23 September 2017

Marit G

3

1 reference

23 September 2017

Pellegrin JL

4

1 reference

23 September 2017

Texier-Maugein J

5

1 reference

23 September 2017

Reiffers J

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 December 1990

1 reference

British Journal of Haematology

23 September 2017

1 reference

23 September 2017

76 Suppl 2

1 reference

23 September 2017

35-40

1 reference

Infection in cancer patients. A continuing association

23 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07934.X

Neutropenia, fever, and infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07934.X

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07934.X

Enterococcal superinfection in patients treated with ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07934.X

In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07934.X

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07934.X

10.1111/J.1365-2141.1990.TB07934.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference